-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The molecular mechanism of pancreatic ductal adenocarcinoma (PDAC) is unclear
Pancreatic ductal carcinoma is one of the most deadly malignant tumors, with a 5-year survival rate of <9%
Recent studies have shown that many oncogenes and mutated tumor suppressor genes, such as c-myc and p53, are involved in regulating tumor cell metabolism
Long intergenic non-coding RNAs (LincRNAs) are a type of biological process regulators, which have been shown to play a role in metabolic regulation
Peroxisome proliferator-activated receptor gamma co-activator 1-α (pPARGC1A or pgc-1α) is the main transcriptional co-regulator involved in metabolic remodeling
In this study, the authors identified a metabolic remodeling ncRNA LINC00842 in PDAC, which can be induced by high glucose, which is a risk factor for the occurrence of PDAC
references
Xudong Huang et al.